UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Two-Year Outcomes of Valoctocogene Roxaparvovec Therapy for Hemophilia A

The New England journal of medicine, 2023-02, Vol.388 (8), p.694-705

2023

Volltextzugriff (PDF)

Effect of late prophylaxis in hemophilia on joint status: a randomized trial

Journal of thrombosis and haemostasis, 2017-11, Vol.15 (11), p.2115-2124

2017

Volltextzugriff (PDF)

Exocrine pancreas glutamate secretion help to sustain enterocyte nutritional needs under protein restriction

American journal of physiology: Gastrointestinal and liver physiology, 2018-04, Vol.314 (4), p.G517-G536

2018

Volltextzugriff (PDF)

Damoctocog Alfa Pegol, a PEGylated B-domain Deleted Recombinant Extended Half-life Factor VIII for the Treatment of Hemophilia A: A Product Review

Drugs in R&D, 2024-09, Vol.24 (3), p.359-381

2024

Volltextzugriff (PDF)

Design of the HEM-POWR study: a prospective, observational study of real-world treatment with damoctocog alfa pegol in patients with haemophilia A

BMJ open, 2021-09, Vol.11 (9), p.e044997-e044997

2021

Volltextzugriff (PDF)

Immunological aspects of inhibitor development

Haemophilia : the official journal of the World Federation of Hemophilia, 2006-12, Vol.12 (s6), p.30-36

REDING, M. T.

2006

Volltextzugriff (PDF)

A laparoscopic approach to address massive splenomegaly, symptomatic cholelithiasis, and a planned postoperative pregnancy: A case report

Clinical case reports, 2023-01, Vol.11 (1), p.e6831-n/a

2023

Volltextzugriff (PDF)

Clinical studies of extended-half-life recombinant FVIII products for prophylaxis in adults and children: A critical review from the physician's perspective

Critical reviews in oncology/hematology, 2022-06, Vol.174, p.103678-103678, Article 103678

2022

Volltextzugriff (PDF)

Anti–Factor Xa and Activated Partial Thromboplastin Time Measurements for Heparin Monitoring in Mechanical Circulatory Support

JACC. Heart failure, 2015-04, Vol.3 (4), p.314-322

2015

Volltextzugriff (PDF)

Compression ignition engine modifications for straight plant oil fueling in remote contexts: Modification design and short-run testing

Fuel (Guildford), 2010-10, Vol.89 (10), p.2925-2938

2010

Volltextzugriff (PDF)

Phase I study of BAY 94‐9027, a PEGylated B‐domain‐deleted recombinant factor VIII with an extended half‐life, in subjects with hemophilia A

Journal of thrombosis and haemostasis, 2014-04, Vol.12 (4), p.488-496

2014

Volltextzugriff (PDF)

Distribution of Th1- and Th2-induced anti-factor VIII IgG subclasses in congenital and acquired hemophilia patients

Thrombosis and haemostasis, 2002-10, Vol.88 (4), p.568-575

2002

Volltextzugriff (PDF)

Integrated Hemophilia Patient Care via a National Network of Care Centers in the United States: A Model for Rare Coagulation Disorders

Journal of blood medicine, 2021-01, Vol.12, p.897-911

2021

Volltextzugriff (PDF)

Safety and efficacy of BAY 94‐9027, a prolonged‐half‐life factor VIII

Journal of thrombosis and haemostasis, 2017-03, Vol.15 (3), p.411-419

2017

Volltextzugriff (PDF)

Randomized, controlled, parallel‐group trial of routine prophylaxis vs. on‐demand treatment with sucrose‐formulated recombinant factor VIII in adults with severe hemophilia A (SPINART)

Journal of thrombosis and haemostasis, 2013-06, Vol.11 (6), p.1119-1127

2013

Volltextzugriff (PDF)

PB2326: SAFE AND EFFECTIVE PROPHYLAXIS WITH PLASMA‐DERIVED FACTOR X CONCENTRATE IN AN ELDERLY PATIENT WITH HEREDITARY FACTOR X DEFICIENCY

HemaSphere, 2022-06, Vol.6 (Suppl), p.2195-2196

2022

Volltextzugriff (PDF)

Target joint resolution in patients with haemophilia A receiving long‐term prophylaxis with BAY 94‐9027

Haemophilia : the official journal of the World Federation of Hemophilia, 2020-07, Vol.26 (4), p.e201-e204

2020

Volltextzugriff (PDF)

Durability testing modified compression ignition engines fueled with straight plant oil

Energy (Oxford), 2010-08, Vol.35 (8), p.3204-3220

2010

Volltextzugriff (PDF)

The impact of obesity on chronic pain in patients with haemophilia: A multicentre retrospective analysis

Haemophilia : the official journal of the World Federation of Hemophilia, 2024-03, Vol.30 (2), p.567-570

2024

Volltextzugriff (PDF)

Prophylaxis use of clotting factor replacement products in people with non‐severe haemophilia: A review of the literature

Haemophilia : the official journal of the World Federation of Hemophilia, 2023-01, Vol.29 (1), p.33-44

2023

Volltextzugriff (PDF)

Radical Cyclization of 2-Alkenylthioanilides: A Novel Synthesis of 2,3-Disubstituted Indoles

Journal of the American Chemical Society, 1999-04, Vol.121 (15), p.3791-3792

1999

Volltextzugriff (PDF)

Decreased Bleeding Rates in Patients with Hemophilia A Switching from Standard-Half-Life FVIII to BAY 94-9027 Prophylaxis

Thrombosis and haemostasis, 2021-08, Vol.121 (8), p.1079-1086

2021

Volltextzugriff (PDF)

Red cell aplasia and autoimmune hemolytic anemia following immunosuppression with alemtuzumab, mycophenolate, and daclizumab in pancreas transplant recipients

Haematologica (Roma), 2007-08, Vol.92 (8), p.1029-1036

2007

Volltextzugriff (PDF)

Human CD4+ T‐cell epitope repertoire on the C2 domain of coagulation factor VIII

Journal of thrombosis and haemostasis, 2003-08, Vol.1 (8), p.1777-1784

2003

Volltextzugriff (PDF)

Response of complex immune-mediated thrombocytopenia to romiplostim in the setting of allogeneic stem cell transplantation for chronic myelogenous leukemia

European journal of haematology, 2012-10, Vol.89 (4), p.361-364

2012

Volltextzugriff (PDF)

1 – 25 von 2.188

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.729)
Mit Volltextzugriff
(1.667)

Publikationsform

5 weitere anzeigen...

Weniger anzeigen...

Sprache

5 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(827)
EZB Electronic Journals Library
(785)
Ingenta
(704)
Journals@Ovid Ovid Full Text
(702)
Access via Wiley Online Library
(360)
Standalone journals
(319)
Access via ScienceDirect (Elsevier)
(300)
IngentaConnect Journals
(282)
Wiley Online Library
(237)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(159)
JSTOR
(120)
Oxford Journals
(111)
SpringerNature Journals
(98)
Ebook Central Perpetual and DDA
(95)
eBooks on EBSCOhost
(93)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(71)
Taylor & Francis eBooks A-Z
(69)
Access via Business Source (EBSCOhost)
(64)
Sage Journals
(59)
Project MUSE
(45)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Two-Year Outcomes of Valoctocogene Roxaparvovec Therapy for Hemophilia A

Effect of late prophylaxis in hemophilia on joint status: a randomized trial

Exocrine pancreas glutamate secretion help to sustain enterocyte nutritional needs under protein restriction

Damoctocog Alfa Pegol, a PEGylated B-domain Deleted Recombinant Extended Half-life Factor VIII for the Treatment of Hemophilia A: A Product Review

Design of the HEM-POWR study: a prospective, observational study of real-world treatment with damoctocog alfa pegol in patients with haemophilia A

Immunological aspects of inhibitor development

A laparoscopic approach to address massive splenomegaly, symptomatic cholelithiasis, and a planned postoperative pregnancy: A case report

Clinical studies of extended-half-life recombinant FVIII products for prophylaxis in adults and children: A critical review from the physician's perspective

Anti–Factor Xa and Activated Partial Thromboplastin Time Measurements for Heparin Monitoring in Mechanical Circulatory Support

Compression ignition engine modifications for straight plant oil fueling in remote contexts: Modification design and short-run testing

Phase I study of BAY 94‐9027, a PEGylated B‐domain‐deleted recombinant factor VIII with an extended half‐life, in subjects with hemophilia A

Distribution of Th1- and Th2-induced anti-factor VIII IgG subclasses in congenital and acquired hemophilia patients

Integrated Hemophilia Patient Care via a National Network of Care Centers in the United States: A Model for Rare Coagulation Disorders

Safety and efficacy of BAY 94‐9027, a prolonged‐half‐life factor VIII

Randomized, controlled, parallel‐group trial of routine prophylaxis vs. on‐demand treatment with sucrose‐formulated recombinant factor VIII in adults with severe hemophilia A (SPINART)

PB2326: SAFE AND EFFECTIVE PROPHYLAXIS WITH PLASMA‐DERIVED FACTOR X CONCENTRATE IN AN ELDERLY PATIENT WITH HEREDITARY FACTOR X DEFICIENCY

Target joint resolution in patients with haemophilia A receiving long‐term prophylaxis with BAY 94‐9027

Durability testing modified compression ignition engines fueled with straight plant oil

The impact of obesity on chronic pain in patients with haemophilia: A multicentre retrospective analysis

Prophylaxis use of clotting factor replacement products in people with non‐severe haemophilia: A review of the literature

Radical Cyclization of 2-Alkenylthioanilides: A Novel Synthesis of 2,3-Disubstituted Indoles

Decreased Bleeding Rates in Patients with Hemophilia A Switching from Standard-Half-Life FVIII to BAY 94-9027 Prophylaxis

Red cell aplasia and autoimmune hemolytic anemia following immunosuppression with alemtuzumab, mycophenolate, and daclizumab in pancreas transplant recipients

Human CD4+ T‐cell epitope repertoire on the C2 domain of coagulation factor VIII

Response of complex immune-mediated thrombocytopenia to romiplostim in the setting of allogeneic stem cell transplantation for chronic myelogenous leukemia

Suchergebnisse filtern